Gastrointestinal Cancer

The Role of the Gut Microbiome in Gastrointestinal Cancer Development

by

IntroductionThe gut microbiome: a dynamic ecosystemMicrobial dysbiosis and CRCGastric cancer and Helicobacter pyloriMicrobial metabolites and host signalingHost immune response and tumor microenvironmentClinical implications and future directionsReferencesFurther reading This article explains how host–microbiome interactions contribute to gastrointestinal cancer risk through microbial genotoxins, metabolic signaling pathways, immune dysregulation, and tumor microenvironment remodeling in colorectal and gastric cancers. … Read more

Cancer Vaccines Begin to Take Center Stage With Investigators Anticipating an Even Brighter Future

by

Vaccines are a major topic of interest in the world of cancer care, offering the promise of an effective treatment option in traditionally hard-to-manage tumor types that can potentially be personalized for individual patients. In order to further elucidate the current role of vaccines in the therapeutic paradigm of multiple tumor types and learn more … Read more

Immune Checkpoint Inhibitors Retain Their Role in the HCC Treatment Paradigm

by

Updated data from key trials with immune checkpoint inhibitor (ICI) regimens, including those from the 4-year overall survival (OS) analysis of the phase 3 HIMALAYA trial (NCT03298451), continue to show why ICI-based combinations are the frontline treatment of choice for patients with hepatocellular carcinoma (HCC), according to Gentry King, MD. “[HIMALAYA was] another study that … Read more

Senolytic agent ABT-263 mitigates GI cancer risk after radiation exposure

by

A new research paper was published by Aging (Aging-US) on January 8, 2025, in Volume 17, Issue 1, titled “Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice.” Researchers Kamendra Kumar, Bo-Hyun Moon, Santosh Kumar, Jerry Angdisen, Bhaskar V.S. Kallakury, Albert J. Fornace Jr., and Shubhankar Suman from Georgetown University Medical Center explored whether a drug called ABT-263 … Read more